Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis is a research paper published in CHEST Journal (2020). On theSindex it has a DataRank of 0.578. It has been cited 46 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.578
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCATS NIH HHS
Grant: UL1 TR002243
NHLBI NIH HHS
Grant: K24 HL127301
NHLBI NIH HHS
Grant: R01 HL117074
National Institutes of Health
Grant: 5UL1TR002243-05
Vanderbilt Institute for Clinical and Translational Research (VICTR)
National Institutes of Health
Grant: 5R01HL117074-05
Microbial induction of sarcoidosis CD4+ T cell dysfunction
National Institutes of Health
FWCI
2.49
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals